Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.